Keywords: Bacillus Calmette-Guerin; Bladder carcinoma; Cystectomy; Sexual function preserving; Prostate sparing; Neobladder; BC; bladder cancer; BCG; bacillus Calmette-Guérin; CSM; Cancer specific mortality; CSS; Cancer specific survival; CIS; carcinoma in situ; CIC; clean intermittent cat
مقالات ISI Bacillus Calmette-Guerin (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Bacillus Calmette-Guerin; ureter; kidney; carcinoma in situ; urothelium; prognosis; BCG; bacillus Calmette-Guérin; B-CIS; bladder CIS; c-CIS; concomitant CIS; CIS; carcinoma in situ; CSS; cancer specific survival; p-CIS; pure/primary CIS; RNU; radical nephroureterectomy; UTUC; up
Keywords: Bacillus Calmette-Guerin; UIP; Universal Immunization Program; EPI; Expanded Program on Immunization; DLHS; District Level Household and Facility Survey; BCG; Bacillus Calmette-Guerin; DPT; Diphtheria-Pertussis-Tetanus; OPV; Oral Polio Vaccine; NFHS; National Family Health Survey;
Keywords: Bacillus Calmette-Guerin; BCG; Bacillus Calmette-Guérin; DHS; Demographic Health Survey; DTP; diphtheria-tetanus-pertussis; EPI; Expanded Program on Immunization; Hib; Haemophilus influenzae type b; MCV; Measles-containing vaccine; OPV; oral polio vaccine; PCV10; 10-valent pneumo
Keywords: Bacillus Calmette-Guerin; Cystectomy; Nonmuscle-invasive bladder cancer; High risk; Bacillus Calmette-Guerin; CistectomÃa; Cáncer vesical no músculo infiltrante; Alto riesgo; Bacilo de Calmette-Guerin;
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; hematuria; pathology; molecular; RNA; messenger; early detection of cancer; ABL1; ABL proto-oncogene 1; ANXA10; annexin 10; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CRH; corticotropin releasin
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: Bacillus Calmette-Guerin; Vaccination; Europe; Policy; Decision-making; Coverage; Performance; BCG; Bacillus Calmette-Guerin; CR; centralised registry; DTP; diphtheria tetanus pertussis; ECDC; European Centre for Disease Prevention and Control; EIR; electronic immunisation record;
Keywords: Bacillus Calmette-Guerin; HA; hyaluronic acid; Tregs; regulatory T cells; T1DM; type 1 diabetes mellitus; IBD; inflammatory bowel disease; RA; rheumatoid arthritis; MHC; major histocompatibility complex; HLA; human leukocytes antigens; TLRs; toll-loke receptors; PRRs; pattern reco
Keywords: Bacillus Calmette-Guerin; Bladder cancer; Bacillus Calmette-Guérin; Efficacy; Toxicity; Cáncer de vejiga; Bacilo de Calmette-Guérin; Eficacia; Toxicidad;
Keywords: Bacillus Calmette-Guerin; leprosy; nerve damage; Amazonia; Brazil; BCG; Bacillus Calmette-Guérin; CHW; Community health workers; UREMC; Sanitary Dermatology Unit “Dr. Marcello Cândia”; WHO; World Health Organization;
Keywords: Bacillus Calmette-Guerin; Vaccinations; Autoimmunity; Lymphoproliferation; Military personnel; Microarray analysis; Apoptotic self-epitopes; BCG; Bacillus Calmette-Guérin; CDC; Centers for Disease Control and Prevention; Td; tetanus/diphtheria; MMR; measles/mumps/rubella; HA; hep
Keywords: Bacillus Calmette-Guerin; Non-muscle-invasive bladder cancer; Intermediate risk; Bacillus Calmette-Guérin; BCG;
Keywords: Bacillus Calmette-Guerin; AT-Rich interaction domain 1A; Bacillus Calmette-Guérin; DNA damage repair; Genomics; Immunotherapy; Nonmuscle invasive bladder cancer; Targeted therapy;
Keywords: Bacillus Calmette-Guerin; ADCC; antibody dependent cellular cytotoxicity; ADCP; antibody-dependent cellular phagocytosis; BCG; bacillus calmette-guérin; CDC; complement-dependent cytotoxicity; CSF-1; colony stimulating factor 1; CTL; cytotoxic T lymphocyte; EGFR; epithelial growt
Keywords: Bacillus Calmette-Guerin; Childhood immunization; Socioeconomic factors; Community characteristics; Complete immunization; Child health; Malawi; BCG; bacillus Calmette-Guérin; DPT; diphtheria-tetanus-pertussis; OVP; oral polio vaccine; MCV; measles-containing vaccine; GEE; genera
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; neoplasm recurrence; local; diagnostic techniques; urological; molecular diagnostic techniques; biomarkers; tumor; BCG; bacillus Calmette-Guérin; EORTC; European Organisation for Research and Treatment of Cancer; NPV; negative
Keywords: Bacillus Calmette-Guerin; BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; administration; intravesical; BCG vaccine; mitomycin; interferons; BCG; bacillus Calmette-Guérin; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; SOE; strength of evidence; TURBT; transurethral bladder tumor resecti
Keywords: Bacillus Calmette-Guerin; bladder neoplasms; risk assessment; practice guidelines as topic; mortality; BCG vaccine; BCG; bacillus Calmette-Guérin; CUETO; Club Urológico Español de Tratamiento Oncológico; EORTC; European Organization for Research and Treatment of Cancer; NCCN®
Keywords: Bacillus Calmette-Guerin; 5-FC; 5-fluorocytosine; 5-FU; 5-fluorouracil; 6-MeP; 6-methylpruine; 6-MeP-dR; 6-methylpurine-2-deoxyriboside; 9-AC; 9-aminocamptothecin; 9-ACG; 9-aminocamptothecin glucuronide; ACV; acyclovir; ADEPT; antibody-directed enzyme prodrug therapy; API; active
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; cystectomy; neoplasm recurrence; local; patient selection; morbidity; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CG; Clavien grade; CIS; carcinoma in situ; DSS; disease specific survival; LVI; lymphovascular invasion;
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; tumor markers, biological; algorithms; urine; diagnosis; BCG; bacillus Calmette-Guérin; EAU; European Association of Urology; LR; likelihood ratio; PPV; positive predictive value;
Keywords: Bacillus Calmette-Guerin; epidemiology; TB; TB prevention; BCG; Bacillus Calmette-Guérin; IGRA; interferon-gamma release assay; LTBI; latent TB infection; TST; tuberculin skin test;
Keywords: Bacillus Calmette-Guerin; AHEI; acute haemorrhagic edema of infancy; ANCA; anti-neutrophil cytoplasmic antibodies; BCG; Bacillus Calmette-Guerin; CHCC; Chapel Hill Consensus conference; CSVV; cutaneous small vessel vasculitis; CV; cutaneous vasculitis; C3, C4, C1q; serum complemen
Keywords: Bacillus Calmette-Guerin; Asthma; Wheeze; Children; Meta-analysis; Protective factors; Risk factors; AMSTAR; Assess Systematic Reviews; BCG; Bacillus Calmette-Guérin; BMI; Body mass index; CO; Carbon monoxide; CI; Confidence intervals; ETS; Environmental tobacco smoke; GER; Gastr
Keywords: Bacillus Calmette-Guerin; CanL; canine leishmaniasis; VL; visceral leishmaniasis; PK; phamacokinetic; SbV; pentavalent antimonials; ROS; reactive oxygen species; BCG; Bacillus Calmette-Guérin; FML; fucose and mannose ligand; Canine leishmaniasis; Leishmania infantum; Prevention;
Keywords: Bacillus Calmette-Guerin; Hybrid molecules; Anti-fungal; Anti-tubercular; Anti-malarial; anti-inflammatory; ACTs; artemesinin based combination therapy; CQ; chloroquine; CC50; concentration required to reduce growth by 50%; EC50; half maximal effective concentration; Fqa; ferroqui
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; biopsy; neoplasm recurrence; local; cystoscopy; cytology; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CT; computerized tomography; PFS; progression-free survival; RFS; recurrence-free survival; TURBT; transurethral r
Keywords: Bacillus Calmette-Guerin; urinary bladder; urothelium; carcinoma; neoplasm grading; mortality; BCG; bacillus Calmette-Gúerin; HG; high grade; LG; low grade; MG; mixed grade;
Keywords: Bacillus Calmette-Guerin; incidence; urinary bladder neoplasms; neoplasm staging; Spain; BC; bladder cancer; BCG; bacillus Calmette-Guérin; BMI; body mass index; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral bladder tumor
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; risk; AUA; American Urological Association; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Club Urologico Espanol de Tratamiento Oncologi
Evaluation of the immunogenic capability of the BCG strains BCGÎBCG1419c and BCGÎBCG1416c in a three-dimensional human lung tissue model
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guérin; Tuberculosis; Granulomas; Immunogenicity; Vaccine;
Bacillus Calmette-Guerin (BCG) vaccine in Iran
Keywords: Bacillus Calmette-Guerin; Tuberculosis; Bacillus Calmette-Guerin;
The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; carcinoma; polymorphism; single nucleotide; receptors; calcitriol; BCG vaccine; 1,25-VD; activated vitamin D; BCG; bacillus Calmette-Guérin; NMIBC; nonmuscle invasive bladder cancer; PCR; polymerase chain reaction; SNP; single
Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study
Keywords: Bacillus Calmette-Guerin; Nonmuscle-invasive bladder cancer; Bacillus Calmette-Guérin; Upper tract urothelial carcinoma;
Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guérin therapy
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guérin; Immunotherapy; Purified protein derivatives; Treatment outcome; Urinary bladder neoplasms;
The influence of interferon-β supplemented human dendritic cells on BCG immunogenicity
Keywords: Bacillus Calmette-Guerin; Tuberculosis; Bacillus Calmette-Guérin; Interferon-beta; Dendritic cells; Cytokines;
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Keywords: Bacillus Calmette-Guerin; bladder neoplasms; neoplasm recurrence; local; carcinoma in situ; cystoscopy; optical imaging; AE; adverse event; BCG; bacillus Calmette-Guérin; BL; blue light; BLC; BL cystoscopy; BLFC; flexible BLC; CIS; carcinoma in situ; HAL; hexaminolevulinate; PDD;
Indicación de cistectomÃa precoz en el cáncer vesical no músculo infiltrante. Revisión de la literatura
Keywords: Bacillus Calmette-Guerin; CistectomÃa; Cáncer vesical no músculo infiltrante; Alto riesgo; Bacilo de Calmette-Guerin; Cystectomy; Nonmuscle-invasive bladder cancer; High risk; Bacillus Calmette-Guerin;
Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guérin; Tuberculosis; Modeling; Economic evaluation;
Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer
Keywords: Bacillus Calmette-Guerin; BC; bladder cancer; BCG; Bacillus Calmette-Guerin; bFGF; basic fibroblast growth factor; BSA; bovine serum albumin; EGF; epidermal growth factor; GFs; growth factors; HGF; hepatocyte growth factor; HRP; horseradish peroxidase; IFN-γ; interferon-gamma; IG
Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; BCG vaccine; adjuvants; immunologic; skin tests; adverse effects; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; LUTS; lower urinary tract symptoms; NMIBC; nonmuscle invasive bladder cancer; PFS; progression-free surviv
Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guerin; Non-muscle-invasive bladder cancer; Maintenance therapy; Recurrence; Progression;
Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer
Keywords: Bacillus Calmette-Guerin; BC; Bladder cancer; BCG; Bacillus Calmette-Guérin; MTBVAC; Mycobacterium tuberculosis vaccine;
Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model
Keywords: Bacillus Calmette-Guerin; 17AAG; 17-Allylamino-17-demethoxygeldanamycin; BCG; Bacillus Calmette-Guerin; DCF; 2â²,7â²-Dichlorofluorescin-diacetate; DLS; Dynamic light scattering; CI; Combination index; CBC; Complete blood count; Fa; Fraction affected; HIF-1α; Hypoxia induced fac
Transdermal immunomodulation: Principles, advances and perspectives
Keywords: Bacillus Calmette-Guerin; AD; atopic dermatitis; AHR; airway hyper responsiveness; APCs; antigen-presenting cells; AS-ODN; antisense oligonucleotide; BCG; Bacillus Calmette-Guérin; CTLs; cytotoxic T cells; dDCs; dermal dendritic cells; DfE; Dermatophagoides farinae extract; EAE;
A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models
Keywords: Bacillus Calmette-Guerin; TB; tuberculosis; MDR; multidrug-resistant; XDR; extensively drug-resistant; TDR; totally drug-resistant; INH; isoniazid; SM; Streptomycin; BCG; bacillus Calmette-Guérin; SAR; structure-activity relationship; WHO; World Health Organization; DprE1/DprE2;
Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study
Keywords: Bacillus Calmette-Guerin; MAL-ED; The Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development; EPI; Expanded Program on Immunization; BGD; Dhaka, Bangladesh; BRF; Fortaleza, Brazil; INV; Vellore, India; N